Oppenheimer & Co’s Aehr Test Systems AEHR Stock Holding History

Oppenheimer & Co’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,720	Closed	-$360K	–	1378
2023 Q2	$360K	Buy	+8,720	New	+$286K	0.01%	1095

Other funds holding AEHR

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co's AEHR Position: Q3 2023 in Review

Oppenheimer & Co sold out of Aehr Test Systems (AEHR) in Q3 2023, closing a stake of 8,720 shares — an estimated $360K sold.

Oppenheimer & Co first reported a position in AEHR in Q2 2023 and held it in 1 quarter. The position peaked at $360K in Q2 2023. 153 funds tracked by Wall St. Rank hold AEHR as of Q3 2023.

Oppenheimer & Co reported no remaining Aehr Test Systems position as of Q3 2023 after selling out during the quarter.
Oppenheimer & Co sold 8,720 Aehr Test Systems shares in Q3 2023, an estimated $360K.
Oppenheimer & Co first reported a position in Aehr Test Systems in Q2 2023 and held it in 1 quarter.
Oppenheimer & Co's Aehr Test Systems position peaked at $360K in Q2 2023.
153 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2023.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.